Nanoparticles succeed in active targeting strategies through the attachment of specific ligands that bind with receptors that are overexpressed on PCa cells while using PSMA ligands, folate receptors, and antibodies or peptides [55, 117]. This evidence concerns the gene FOLH1 and posterior cortical atrophy.